Carregant...
Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected Recipients
Kidney transplantation with hepatitis C viremic (dHCV+) donors appears safe for recipients without HCV when accompanied by direct acting antiviral (DAA) treatment. However, US programs have been reluctant to embrace this approach due to concern about insurance coverage. While the cost of DAA treatme...
Guardat en:
| Publicat a: | Transplant Direct |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Lippincott Williams & Wilkins
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7665247/ https://ncbi.nlm.nih.gov/pubmed/33204825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001056 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|